FCX vs VYGR · P/E 38, rev $25.45B vs rev $80.0M
Freeport-McMoran Copper & Gold Inc (FCX) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
Freeport-McMoran Copper & Gold Inc (FCX) is a copper company listed on US.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported FCX revenue for 2024-12-31 was $25.45B. Net income was $4.40B. Revenue was up 11.4% from 2023-12-31 to 2024-12-31. FCX currently screens at market cap $67.80B and trailing P/E 38.0.
Latest reported VYGR revenue for 2024-12-31 was $80.0M. Net income was -$65.0M. Revenue was down 68.0% from 2023-12-31 to 2024-12-31. VYGR currently screens at market cap $225.4M.
FCX currently screens at market cap $67.80B and trailing P/E 38.0. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the FCX and VYGR stock pages for the full models.
Not investment advice.